Clear answers about 30x whole genome sequencing, health reports, privacy, research participation, blockchain access history, and data control.
DNA testing
Whole genome sequencing analyses most of your genome in far greater depth than selected-marker tests. The "30x" means your DNA is read many times over to improve confidence in the result and create a stronger foundation for future reports. No sequencing method covers every genomic position perfectly.
Many consumer DNA tests check selected points in your DNA. MyDNABank is designed around 30x whole genome sequencing, which analyses much more of your genome than a small selection of markers. This creates a broader genomic record for deeper health reports and future reanalysis.
Publicly, 30x WGS is currently on a waiting list. When you order through MyDNABank, you receive a collection kit, follow the collection instructions provided with the kit (the method may vary by laboratory and service), return the sample to the partner lab, and view reports in the MyDNABank app after sequencing and analysis.
Upload is currently available through limited early access. Join the upload early-access list. Where supported, you can upload data from providers such as 23andMe. Report depth depends on the type, format and quality of the file — some files may support limited reports only.
Health reports
Health reports are already available via our lab partner across longevity, heart health, medication response, nutrition, fitness, family planning, ancestry, sleep and stress, wellbeing, and selected disease risks. App access is live through limited early access. Reports should explain what was analysed, what the result may mean, what it does not mean, and when professional guidance may be needed.
Your inherited genome remains largely the same, but science advances. Supported reports may be updated as new evidence, validated interpretations and platform capabilities become available.
No. Reports should be viewed as health insights and educational information unless reviewed through an appropriate clinical pathway. Actionable findings should be discussed with a qualified healthcare professional or genetic counsellor.
App and updates
Yes. The app is live through limited early access as your personal genome dashboard for health reports, privacy controls, new insight alerts, access history, and research requests.
Yes. Research requests are shown separately from your health reports, so you can review who is asking, what they want to study, and what type of analysis is requested.
Privacy and security
No. Your raw genomic file never leaves the controlled environment. If you consent to a research or precision medicine request, approved analysis runs inside that environment, and only permitted results are returned.
No. Your genomic data is not sold as a product. You remain the owner and may choose to permit controlled research use in secure compute environments. Organisations accessing data under commercial research terms are required to provide compensation, unless you explicitly choose to permit access without compensation. Your raw genomic file never leaves the controlled environment. If you do not consent, your data is not used for that request.
No. MyDNABank is designed for personal health insight and approved research access, not employer, insurer, advertiser, or data broker access.
No. Raw DNA data is stored off-chain in protected systems. Blockchain is already deployed as an extra event-logging layer for tamper-evident access history — not public storage of your genome.
MyDNABank uses encryption before upload, access controls, audit history, governed analysis, and separation between raw DNA data storage and approved research outputs. Your account is intended to be controlled by you — access to reports, privacy settings and research controls should require secure authentication.
Research participation
No. Research participation is optional. You review each request and approve or decline based on the stated purpose, access terms, and consent options.
Yes. You can revoke future access according to the approved terms. Revocation stops future access only; an ongoing approved study is not interrupted. Completed analysis cannot be undone, and the change is recorded in the audit history.
Organisations accessing data under commercial research terms are required to provide compensation, unless you explicitly choose to permit access without compensation. Terms are shown before you approve. Research matching and participation are not guaranteed.
Data control
Your genomic data should remain portable and accessible to you — export options are available inside your account where supported. You can also request deletion now, in line with applicable data protection laws, including GDPR. Audit records may need to be retained for compliance, security and traceability, but these records do not contain your raw DNA data.
For researchers and partners
See For researchers and Biotech and precision medicine for cohort discovery, GA4GH standards and partner pathways.
Genetic information can be useful, but it should not be treated as a complete diagnosis. Medical decisions should involve qualified healthcare professionals. MyDNABank reports should be viewed as health insights and educational information unless reviewed through an appropriate clinical pathway.
Your genome is deeply personal. MyDNABank already supports B2C consent controls and B2B research access, with encryption before upload, controlled analysis, and access history.